Global Heart Valves Market 2016-2020

  • ID: 3769381
  • Report
  • Region: Global
  • 67 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardious
  • corlife OHG
  • JenaValve Technology
  • Medtronic
  • Neovasc
  • MORE
About the Heart Valves Market

Heart valves are prosthetic cardiovascular medical devices used to replace a defective heart valve. They can be biological, tissue or mechanical. Manufacturers develop mechanical heart valves from synthetic materials such as pyrolytic carbon, titanium alloy, and cobalt-based alloys and tissue heart valves from bovine, porcine, and human tissues. They also develop transcatheter heart valves with a combination of tissue and synthetic materials. Devices developed using human tissues are known as allografts or homografts. Medical personnel implant transcatheter heart valves through the transfemoral approach (via the femoral artery) and transapical approach (via a small chest incision). Medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.

The analysts forecast the global heart valves market to grow at a CAGR of 14.28% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global heart valves market for 2016-2020.

To calculate the market size, we consider revenue generated from the sales of prosthetic heart valve products such as:

- Mechanical heart valves: Caged ball, tilting disc, and bileaflet valves
- Tissue heart valves: Stented and stentless tissue valves
- Transcatheter heart valves: Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR) devices

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Edwards Lifesciences
- LivaNova
- Medtronic
- St. Jude Medical

Other prominent vendors
- Abbott Laboratories
- Braile Biomedica
- Cardious
- Colibri Heart Valve
- corlife OHG
- JenaValve Technology
- Lepu Medical Technology (Beijing)
- Meril Life Sciences
- Neovasc
- ON-X Life Technologies
- Pulmonx
- Roskardioinvest
- SYMETIS

Market drivers
- Implementation of minimally invasive procedures

Market trends
- Use of stentless tissue valves

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardious
  • corlife OHG
  • JenaValve Technology
  • Medtronic
  • Neovasc
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Cost analysis
  • Cost analysis of valve replacement procedures
PART 07: Market segmentation by product
  • Global mechanical heart valves market
  • Global tissue heart valves market
  • Global transcatheter heart valves market
PART 08: Geographical segmentation
  • Heart valves market in Americas
  • Heart valves market in EMEA
  • Heart valves market in APAC
PART 09: Market drivers
  • Incidence of heart valve diseases
  • Implementation of minimally invasive procedures
  • Use of transcatheter valve replacement technology
  • Rise in older population
PART 10: Impact of drivers

PART 11: Market challenges
  • Risk of potential complications
  • Lack of skilled personnel
  • Expensive heart valve replacement procedures
  • Stringent regulatory framework
PART 12: Impact of drivers and challenges

PART 13: Market trends
  • Focus on US
  • Increase in M&A
  • Use of stentless tissue valves
  • Development of novel heart valves
PART 14: Vendor landscape
  • Competitive scenario
  • Market share analysis 2015
  • Key vendors
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
PART 16: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Global heart valves market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
Exhibit 05: Global heart valves market segmentation by product
Exhibit 06: Global heart valves market segmentation by product 2015
Exhibit 07: Global heart valves market segmentation by product 2020
Exhibit 08: Global heart valves market segmentation by product 2015-2020
Exhibit 09: Global mechanical heart valves market segmentation by type
Exhibit 10: Characteristics of mechanical valves
Exhibit 11: Global mechanical heart valves market 2015-2020 ($ millions)
Exhibit 12: Global tissue heart valves market segmentation by type 2015
Exhibit 13: Global tissue heart valves market 2015-2020 ($ billion)
Exhibit 14: Global transcatheter heart valves market by type 2015
Exhibit 15: Global transcatheter heart valves market 2015-2020 ($ billions)
Exhibit 16: Global heart valves market segmentation by geography 2015
Exhibit 17: Global heart valves market segmentation by geography 2020
Exhibit 18: Global heart valves market segmentation by geography 2015-2020
Exhibit 19: Heart valves market in Americas 2015-2020 ($ billions)
Exhibit 20: Heart valves market in EMEA 2015-2020 ($ billions)
Exhibit 21: Heart valves market in APAC 2015-2020 ($ billions)
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Major acquisitions 2015
Exhibit 25: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 26: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 27: Ranking of top vendors in global tissue heart valves market 2015
Exhibit 28: Edwards Lifesciences: Business segmentation by revenue 2015
Exhibit 29: Edwards Lifesciences: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 30: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment 2013-2015 ($ millions)
Exhibit 31: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in US 2013-2015 ($ millions)
Exhibit 32: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in ROW 2013-2015 ($ millions)
Exhibit 33: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment 2013-2015 ($ millions)
Exhibit 34: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in US 2013-2015 ($ millions)
Exhibit 35: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in ROW 2013-2015 ($ millions)
Exhibit 36: Edwards Lifesciences: Key takeaways
Exhibit 37: LivaNova: Revenue of cardiac surgery segment by geography 2015
Exhibit 38: LivoNova: Key takeaways
Exhibit 39: Medtronic: Product portfolio
Exhibit 40: Medtronic: Product segmentation by revenue 2015
Exhibit 41: Medtronic: Key takeaways
Exhibit 42: St. Jude Medical: Product portfolio
Exhibit 43: St. Jude Medical: Revenue and YoY growth of structural heart segment 2013-2015 ($ millions)
Exhibit 44: St. Jude Medical: Key takeaways
Exhibit 45: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Cardious
  • corlife OHG
  • JenaValve Technology
  • Medtronic
  • Neovasc
  • MORE
New Report Released: - Global Heart Valves Market 2016-2020

The author of the report recognizes the following companies as the key players in the global heart valves market: Edwards Lifesciences, LivaNova, Medtronic and St. Jude Medical.

Other Prominent Vendors in the market are: Abbott Laboratories, Braile Biomedica, Cardious, Colibri Heart Valve, corlife OHG, JenaValve Technology, Lepu Medical Technology (Beijing), Meril Life Sciences, Neovasc, ON-X Life Technologies, Pulmonx, Roskardioinvest, and SYMETIS.

Commenting on the report, an analyst from the research team said: “A trend which is having a huge impact on the market is the use of stentless tissue valves. Physicians prefer stentless tissue valves as they have a wider valve opening. This allows the blood to flow more freely. Stentless tissue heart valves are flexible, and have a wider valve opening, which helps the blood to avoid a damaged stent in the heart and flow uniformly. Stentless tissue valves are also durable and last for a longer duration compared to stented tissue valves. These factors help physicians provide better treatment for heart valve diseases.”

According to the report, a key growth driver is the implementation of minimally invasive procedures. Physicians use invasive and MI procedures, such as sternotomy and thoracotomy, to implant mechanical, tissue, and transcatheter heart valves in people with heart valve diseases. However, invasive methods can cause pleural effusion, arrhythmia, pleuritis, pericardial effusion, pericarditis, and infections in the lungs. This has led physicians to opt for minimally invasive surgeries for device implantation. Minimally invasive catheter-based procedures help improve the quality of life. These procedures for the implantation of heart valves have proven to be safe and efficient. They reduce the need for blood transfusions, the risk of infections, and hospital stays; cause minimal blood loss and less pain and scarring; and lead to rapid healing and recovery and better clinical outcome.

Further, the report states that one challenge that could restrict market growth is the expense involved in heart valve replacement procedures. Heart valve replacement procedures are recent advances in the field of medical technology and expensive. This results in people with heart valve diseases avoiding associated replacement procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Edwards Lifesciences
- LivaNova
- Medtronic
- St. Jude Medical
- Abbott Laboratories
- Braile Biomedica
- Cardious
- Colibri Heart Valve
- corlife OHG
- JenaValve Technology
- Lepu Medical Technology (Beijing)
- Meril Life Sciences
- Neovasc
- ON-X Life Technologies
- Pulmonx
- Roskardioinvest
- SYMETIS.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll